Who benefits most from adjuvant interferon treatment for melanoma?
Helen Gogas, Huseyin Abali, Paolo A. Ascierto, Lev Demidov, Hubert Pehamberger, Caroline Robert, Jacob Schachter, Alexander M.M. Eggermont, Axel Hauschild, Enrique Espinosa
Research output: Contribution to journal › Article › peer-review
15Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Who benefits most from adjuvant interferon treatment for melanoma?'. Together they form a unique fingerprint.